1.0Avalere Health Advisoryhttps://advisory.avalerehealth.comMegan West (Olsen) | Avalere Health Advisoryrich600338<blockquote class="wp-embedded-content" data-secret="v0SALaKOSs"><a href="https://advisory.avalerehealth.com/team/megan-olsen">Megan West (Olsen)</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://advisory.avalerehealth.com/team/megan-olsen/embed#?secret=v0SALaKOSs" width="600" height="338" title="“Megan West (Olsen)” — Avalere Health Advisory" data-secret="v0SALaKOSs" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
Megan West advises clients on policy and market-based strategies related to drug pricing, cell and gene therapy (CGT) development, value-based contracting, and innovative approaches to patient access. In recent projects, Megan has helped life sciences manufacturers assess how drug pricing reforms in the Inflation Reduction Act will impact their businesses, convening stakeholders across functional units…